ES2191662T3 - Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales. - Google Patents

Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales.

Info

Publication number
ES2191662T3
ES2191662T3 ES93904475T ES93904475T ES2191662T3 ES 2191662 T3 ES2191662 T3 ES 2191662T3 ES 93904475 T ES93904475 T ES 93904475T ES 93904475 T ES93904475 T ES 93904475T ES 2191662 T3 ES2191662 T3 ES 2191662T3
Authority
ES
Spain
Prior art keywords
polyhydroxi
benzamide
derivatives
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93904475T
Other languages
English (en)
Inventor
Howard L Elford
T Riet Bartholomeus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLECULES FOR HEALTH Inc
Original Assignee
MOLECULES FOR HEALTH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLECULES FOR HEALTH Inc filed Critical MOLECULES FOR HEALTH Inc
Application granted granted Critical
Publication of ES2191662T3 publication Critical patent/ES2191662T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRESENTA UN PROCESO TERAPEUTICO PARA TRATAR UNA ENFERMEDAD EN LOS MAMIFEROS PROVOCADA POR VIRUS DE DNA O RETROVIRUS, EN LA QUE EL MAMIFERO TRATADO SE TRATA CON UN DERIVADO DEL ACIDO BENZOICO, MANDELICO O FENILACETICO, TAL COMO LA N, 3,4-TRIHIDROXIBENZAMIDA.
ES93904475T 1991-10-31 1992-10-29 Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales. Expired - Lifetime ES2191662T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78598291A 1991-10-31 1991-10-31

Publications (1)

Publication Number Publication Date
ES2191662T3 true ES2191662T3 (es) 2003-09-16

Family

ID=25137227

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93904475T Expired - Lifetime ES2191662T3 (es) 1991-10-31 1992-10-29 Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales.

Country Status (5)

Country Link
US (1) US6248782B1 (es)
EP (1) EP0610444B1 (es)
DE (1) DE69232911T2 (es)
ES (1) ES2191662T3 (es)
WO (1) WO1993012782A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273700T1 (de) 1993-05-21 2004-09-15 Us Gov Health & Human Serv Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren
US6093702A (en) * 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US6713517B1 (en) 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
US6028111A (en) * 1996-03-08 2000-02-22 Oxigene, Inc. Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
WO2002085358A2 (en) * 2001-04-20 2002-10-31 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
CA2564868C (en) * 2004-04-28 2013-11-26 Molecules For Health, Inc. Methods for treating or preventing restenosis and other vascular proliferative disorders
EP2030615A3 (en) 2007-08-13 2009-12-02 ELFORD, Howard L. Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases
WO2011084619A2 (en) * 2009-12-16 2011-07-14 Mark Stahl Elimination of pathogenic infection in farmed animal populations
MD4132C1 (ro) * 2010-12-13 2012-05-31 Государственный Университет Молд0 Di(µ-S)-bis{cloro-[fenil(piridin-2-il)metanon-tiosemicarbazonato(1-)]cupru} care manifestă proprietatea de inhibare a proliferării celulelor T-47D ale cancerului mamar
CN104434890A (zh) * 2013-09-24 2015-03-25 上海市计划生育科学研究所 扁桃酸的用途
WO2020176349A1 (en) * 2019-02-25 2020-09-03 The Regents Of The University Of California Nnythiosemicarbazone compounds and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US647940A (en) * 1899-02-01 1900-04-24 Gen Electric System of train control.
US1715251A (en) * 1924-12-24 1929-05-28 Sabalitschka Theodor Disinfecting
US2952583A (en) * 1958-11-05 1960-09-13 Dow Chemical Co Composition and method for controlling plant viruses
SU393031A1 (ru) 1972-01-03 1973-08-10 Металлический стержень для литейных форм
US4623659A (en) * 1983-05-23 1986-11-18 Riet Bartholomeus Van T Polyhydroxybenzoic acid derivatives
FR2550785B1 (fr) * 1983-08-18 1985-12-06 Sanofi Sa Nouvelles compositions a activite antimicrobienne contenant des derives de l'acide benzoique, leur procede de preparation, leur utilisation en tant que medicaments desinfectants ou conservateurs
JPS62149666A (ja) 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
DE3715281A1 (de) * 1987-05-05 1988-11-24 Kroeger Hans Neue antiviral wirksame substanz
US5110799A (en) * 1989-07-28 1992-05-05 Merck & Co., Inc. Antiherpetic agents
ATE273700T1 (de) 1993-05-21 2004-09-15 Us Gov Health & Human Serv Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren
US6093702A (en) 1993-12-20 2000-07-25 The United States Of America As Represented By The Department Of Health And Human Services Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
US5521161A (en) 1993-12-20 1996-05-28 Compagnie De Developpment Aguettant S.A. Method of treating HIV in humans by administration of ddI and hydroxycarbamide

Also Published As

Publication number Publication date
DE69232911D1 (de) 2003-03-06
EP0610444A1 (en) 1994-08-17
WO1993012782A1 (en) 1993-07-08
DE69232911T2 (de) 2003-11-13
US6248782B1 (en) 2001-06-19
EP0610444A4 (en) 1995-05-17
EP0610444B1 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
ES2191662T3 (es) Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales.
BR9913157A (pt) Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto
UY26332A1 (es) Nuevos derivados del ácido aminodicarboxílico con propiedades farmacéuticas.
ES2152222T3 (es) Sulfonamidas, su preparacion y su uso como medicamento e intermedio.
MX9403380A (es) Inhibidores de proteasa de vih utiles para el tratamiento de sida.
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
BRPI0210941B8 (pt) produto farmacêutico contendo combinações de oxazolidinonas substituídas, seu uso, seu processo de produção, e medicamento
UY25869A1 (es) Moduladores de ccr5, formulaciones farmacéuticas, procedimientos y sus usos.
UY27333A1 (es) Nucleótidos 4` sustituidos
BR0206435A (pt) Composto, composição farmacêutica, métodos de tratar a angiogênese em um paciente, de tratar distúrbios relacionados com kdr e proliferativos em um mamìfero, uso de um composto, e, processo para preparar compostos
SE8304670D0 (sv) Nya cefem- och cefamforeningar och forfaranden for deras framstellning
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
AR019853A1 (es) Derivado del acido 3-aril-2-hidroxipropionico, proceso e intermediario para su preparacion, formulaciones farmaceuticas, uso de dicho compuesto en laelaboracion de un medicamento, metodo para la profilaxis y/o tratamiento de trastornos clinicos asociados con la resistencia a la insulina, y formulaci
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
ES2138613T3 (es) Derivado de espirooxatiolano-quinuclidina para el tratamiento del sindrome de sjoegren.
CO4130200A1 (es) Inhibidores de proteasa del hiv utiles en el tratamiento del sida
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación
ES2032582T3 (es) Procedimiento para preparar derivados de la oxima del 1,2,5,6,-tetrahidropiridin -3-carboxialdehido.
ES2062407T3 (es) Compuestos de 2-hidroxi-3-fenoxipropilamino.
ES2196456T3 (es) Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen.
UY26307A1 (es) Las rutas sintéticas eficientes para la preparación de los inhibidores de la proteasa del rinovirus y los intermedios claves
GB1059230A (en) Improvements in or relating to therapeutic products
ES2052579T3 (es) Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.